US$ 29.85
tirzepatide schweiz Eli Lilly's diabetes drug tirzepatide
Description
Prof Sir Stephen ORahilly, a professor of clinical biochemistry and medicine at Cambridge University, said that given increasing rates of dangerous weight gain, medicines such as tirzepatide will become a central plank of how we help people living with obesity to live longer and healthier lives

FernandoKConnollyDDarcyEEvansMHinchliffeWHolmesPet al

Tirzepatide is indicated an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial BMI of 30 (obesity) or 27 (overweight) in the presence of at least one weight-related comorbid condition (eg, hypertension, dyslipidemia, T2D, obstructive sleep apnea, or CVD)
It is an artificial peptide-based variant of exendin- 4, an incretin mimetic [87]
